2018.10.10

Nyuen Biotechnology Co. Ltd. was established, and the R&D center commenced operations.

2019.06

Established a strategic partnership with ThermoFisher to create a central nervous system demonstration laboratory.

‍2020.10

Collaborated with Bio-X Institutes of Shanghai Jiao Tong University to co-establish a scientific research transformation base.

2020.11

Formed a strategic partnership with the China Association Against Epilepsy (CAAE) to launch the China Epilepsy Gene 1.0 (C-EPG1.0) project.

‍

2021.04 ‍

Nyuen Biotechnology Co. Ltd. was certified as a high-tech enterprise in Shanghai.

‍‍ ‍ ‍ ‍‍ 2021.06

The Nyuen‍ Medical Testing Laboratory completed construction and passed acceptance inspection.‍‍‍

Participated in the "Leaderboard Champion" project by Hangzhou Science and Technology Bureau and Hangzhou Seventh Hospital.

Became a designated testing institution for regular COVID-19 prevention and control in Minhang District.

Received ISO9001 quality management system certification.

Recognized as an R&D institution in Pudong New Area.

Became a "Strategic Partner" of the Zhejiang Clinical Medical Research Center for Mental and Psychological Diseases‍

‍‍‍‍‍

2023.01

Contributed to the China Epilepsy Gene 1.0 project, discovering a new epilepsy-related gene, BSN.

‍2023.03‍

Awarded the title of "Specialized, Refined, and New" small and medium-sized enterprise in Shanghai.

‍2023.06‍

Participated in a strategic cooperation project with the Shanghai Mental Health Center.